By Mirjana Rajer, MD, PhD Posted: April 1, 2019 For many years, the treatment of patients with stage III lung cancer has been a topic of intense debate among surgeons, radiation […] Read more
By Erik MacLaren, PhD Posted: April 1, 2019 On January 25, 2019, the Director of the National Cancer Institute (NCI) Norman E. Sharpless, MD, participated in a live social media event […] Read more
By Anne-Claire Toffart, MD, PhD, and Jean-François Timsit, MD, PhD Posted: April 1, 2019 Dr. Anne-Claire Toffart Survival rates for patients with lung cancer who were admitted into the intensive care […] Read more
Posted: April 1, 2019 Why TMB Should Be Assessed in Patients with Advanced NSCLC By Fabrice Barlesi, MD, PhD Dr. Fabrice Barlesi Immune checkpoint inhibitors, especially PD-1 and PD-L1 inhibitors, have […] Read more
By Russell Bahar, Bsc and Elliot Wakeam, MD, MPH Posted: April 1, 2019 IN REFERENCE TO: Serna-Gallegos DR, et al Effects of time from completed clinical staging to surgery: Does it […] Read more
By Raymond Niaura, PhD Posted: April 1, 2019 IN REFERENCE TO: Halpern SD, French B, Small DS, et al.Randomized trial of four financial incentive programs for smoking cessation. N Engl J […] Read more
By Andre L. Moreira, MD Posted: April 1, 2019 Most of the progress in thoracic oncology is in the treatment of patients with NSCLC. The determination of subtypes of NSCLC, namely […] Read more
By Richard Booton, MD, PhD, FRCP Posted: April 1, 2019 Dr. Richard Booton The symptomatic presentation of lung cancer is typically associated with advanced disease and poor survival. Screening […] Read more
By Erik MacLaren, PhD Posted: April 1, 2019 In September 2018, several attendees of the 19th World Conference on Lung Cancer (WCLC) in Toronto, Canada, received Travel and Mentorship Awards from […] Read more
By Joy Curzio Posted: April 1, 2019 Lung cancer is the leading cause of cancer death among women, with the 5-year survival rate at just 21%.1 An estimated 70,500 women in […] Read more